← Back

KoBioLabs Inc

348150.KQKRW

2,880-48.1%1Y · KRW

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.

Country

Sector

Packaged Foods & Meats

Also in

Metabolic, Diabetes & Obesity Neuroscience & Neurodegenerative Autoimmune & Immunology Therapeutics

Price · split & dividend adjusted

News & notes moving 348150.KQ